Skip to main content
SpringerLink
Log in
Book cover

Yearbook of Intensive Care and Emergency Medicine 2005 pp 337–348Cite as

Rational Use of Antibiotics in the ICU: Optimum Efficacy for the Lowest Costs

  • Conference paper

  • 651 Accesses

Part of the book series: EN]Yearbook of Intensive Care and Emergency Medicine ((volume 2005))

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bergogne-Berezin E (1997) Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing. J Chemother Suppl 1:109–115

    Google Scholar 

  2. Oberholzer A, Oberholzer C, Moldawer LL (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83–96

    PubMed  Google Scholar 

  3. Polderman KH, Girbes ARJ (2004) Drug intervention trials in sepsis: divergent results. Lancet 363:1721–1723

    Article  PubMed  Google Scholar 

  4. Metlay JP, Singer DE (2002) Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance. Clin Microbiol Infect 8(Suppl 2):1–11

    Article  Google Scholar 

  5. Kollef MH (2000) Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 31(Suppl 4):S131–S138

    Article  PubMed  Google Scholar 

  6. Zaidi M, Sifuentes-Osornio J, Rolon AL, et al (2002) Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. Arch Med Res 33:290–294

    Article  PubMed  Google Scholar 

  7. Zaragoza R, Artero A, Camarena JJ, et al (2003) The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 9:412–418

    PubMed  Google Scholar 

  8. Ibrahim EH, Sherman G, Ward S, et al (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155

    Article  PubMed  Google Scholar 

  9. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474

    Article  PubMed  Google Scholar 

  10. Osmon S, Ward S, Fraser VJ, Kollef MH (2004) Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 125:607–616

    Article  PubMed  Google Scholar 

  11. Greisman SE, DuBuy JB, Woodward CL (1979) Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone. Infect Immun 25:538–557

    PubMed  Google Scholar 

  12. McGarvey RN, Harper JJ (1993) Pneumonia mortality reduction and quality improvement in a community hospital. QRB Qual Rev Bull 19:124–130

    PubMed  Google Scholar 

  13. Dean NC, Silver MP, Bateman KA, et al (2001) Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 110:451–457

    PubMed  Google Scholar 

  14. Meehan, MP, Fine, MJ, Krumbolz, HM, et al (1997) Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 278:2080–2085

    Article  PubMed  Google Scholar 

  15. Houck PM, Bratzler DW, Nsa W, et al (2004) Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164:637–644

    Article  PubMed  Google Scholar 

  16. Fang CT, Chen YC, Chang SC (2000) Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM 93:45–53

    PubMed  Google Scholar 

  17. Aronin SI, Peduzzi P, Quagliarello VJ (1998) Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129:862–869

    PubMed  Google Scholar 

  18. Lu CH, Huang CR, Chang WN, et al (2002) Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg 104:352–358

    Article  PubMed  Google Scholar 

  19. Luna, CM, Vujacich, P, Niederman, MS, et al (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685

    PubMed  Google Scholar 

  20. Ibrahim, EH, Sherman, G, Ward, S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU Chest 118:146–155

    Article  PubMed  Google Scholar 

  21. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:262–268

    Article  PubMed  Google Scholar 

  22. Clec'h C, Timsit JF, De Lassence A, et al (2004) Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity. Intensive Care Med 30:1327–1333

    PubMed  Google Scholar 

  23. Vogtlander NP, Van Kasteren ME, Natsch S, et al (2004) Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy. Arch Intern Med 164:1206–1212

    Article  PubMed  Google Scholar 

  24. MacGowan AP (2001) Role of pharmacokinetics and pharmacodynamics: does the dose matter? Clin Infect Dis 33(Suppl 3):S238–S239

    Article  PubMed  Google Scholar 

  25. Fry DE (1996) The importance of antibiotic pharmacokinetics in critical illness. Am J Surg 172:20S–25S

    Article  PubMed  Google Scholar 

  26. Nicolau DP, Quintiliani R, Nightingale CH (1995) Antibiotic kinetics and dynamics for the clinician. Med Clin North Am 79:477–495

    PubMed  Google Scholar 

  27. Craig WA (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1–30

    PubMed  Google Scholar 

  28. Moore RD, Lietman PS, Smith CR (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155:93–99

    PubMed  Google Scholar 

  29. Kashuba AD, Nafziger AN, Drusano GL, et al (1999) Optimizing aminoglycoside therapy for nosocomial pneumonia caused by Gram-negative bacteria. Antimicrob Agents Chemother 43:623–629

    PubMed  Google Scholar 

  30. Nicolau DP, Freeman CD, Belliveau PP, et al (1995) Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agents Chemother 39:650–655

    PubMed  Google Scholar 

  31. Forrest A, Nix DE, Sallow CH, et al (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37:1073–1081

    PubMed  Google Scholar 

  32. Drusano G, Labro MT, Cars O, et al (1998) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Clin Microbiol Infect 4(Suppl 2):S27–S41

    Google Scholar 

  33. Ambrose PG, Grasela DM, Grasela TH, et al (2001) Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother 45:2793–2797

    Article  PubMed  Google Scholar 

  34. Craig WA, Andes D (1996) Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 15:255–259

    Article  PubMed  Google Scholar 

  35. Schentagg JJ, Smith IL, Swanson DJ, et al (1984) Role for individualization with cefmenoxime. Am J Med 77:43–50

    Google Scholar 

  36. Grant EM, Kuti JL, Nicolau DP, et al (2002) Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital. Pharmacotherapy 22:471–483

    Article  PubMed  Google Scholar 

  37. Craig WA (2002) The role of pharmacodynamics in effective treatment of community-acquired pathogens. Advanced Studies in Medicine 2:126–134

    Google Scholar 

  38. Drusano GL, Craig WA (1997) Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 9(Suppl 3):38–44

    Google Scholar 

  39. Niederman MS (2001) Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 29(Suppl 4):N114–120

    Article  PubMed  Google Scholar 

  40. Lemmen SW, Becker G, FranK U, Daschner FD (2001) Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital. Scand J Infect Dis 33:219–221

    Article  PubMed  Google Scholar 

  41. Thuong M, Shortgen F, Zazempa V, et al (2000) Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation. J Antimicrob Chemother 46:501–508

    Article  PubMed  Google Scholar 

  42. Van Zanten AR, Engelfriet PM, Van Dillen K (2003) Importance of nondrug costs of intravenous antibiotic therapy. Crit Care 7:R184–R190

    Article  PubMed  Google Scholar 

  43. Heyland DK, Rocker GM, Dodek PM, et al (2002) Family satisfaction with care in the intensive care unit: results of a multiple center study. Crit Care Med 30:1413–1418

    Article  PubMed  Google Scholar 

  44. Tarnow-Mordi WO, Hau C, Warden A, Shearer AJ (2000) Hospital mortality in relation to staff workload: a 4-year study in an adult intensive-care unit. Lancet 356:185–189

    Article  PubMed  Google Scholar 

  45. Tucker J, UK Neonatal Staffing Study Group (2002) Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation. Lancet 359:99–107

    Article  PubMed  Google Scholar 

  46. Thorens JB, Kaelin RM, Jolliet P, Chevrolet JC (1995) Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease. Crit Care Med 23:1807–1815

    Article  PubMed  Google Scholar 

Download references

Authors
  1. A.R.H. van Zanten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.H. Polderman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

van Zanten, A., Polderman, K. (2005). Rational Use of Antibiotics in the ICU: Optimum Efficacy for the Lowest Costs. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2005. EN]Yearbook of Intensive Care and Emergency Medicine, vol 2005. Springer, New York, NY. https://doi.org/10.1007/0-387-26272-5_29

Download citation

  • DOI: https://doi.org/10.1007/0-387-26272-5_29

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-3-540-23476-0

  • Online ISBN: 978-0-387-26272-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation